secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zoetis Inc. (ZTS)
CIK:        0001555280
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001555280-25-000100
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zoetis Q4 revenue $2.3B (+5%), adj. EPS $1.40; FY2025 guidance organic growth 6-8%
--------------------------------------------------------------------------------

- Q4 2024 revenue $2.3B (+5% reported, +9% organic operational); reported EPS $1.29, adjusted EPS $1.40.
- FY 2024 revenue $9.3B (+8% reported, +12% organic); reported EPS $5.47, adjusted EPS $5.92.
- U.S. segment revenue $1.3B (+4%); companion animal +7% on Simparica Trio, Apoquel, Librela; livestock -8% on MFA divestiture.
- International segment revenue $1.0B (+6% reported, +10% operational); companion animal +11%, livestock flat.
- FY 2025 guidance: revenue $9.225-9.375B, adjusted EPS $6.00-6.10, organic operational revenue growth 6-8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000100/0001555280-25-000100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1555280/000155528025000100/zts-20250213.htm
  HTML page:      https://secwatch.observer/filing/0001555280-25-000100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer